COVID-19 associated mucormycosis: Staging and management recommendations (Report of a multi-disciplinary expert committee)

Even before the onslaught of COVID-19 pandemic could settle, the unprecedented rise in cases with COVID-19 associated mucormycosis pushed the medical health to the fringe. Hyperglycaemia and corticosteroids appear to be the most consistent associations leading to the commonest manifestation of mucor...

Full description

Bibliographic Details

Published in:	Journal of Oral Biology and Craniofacial Research
Main Authors:	Hardeep Singh Malhotra, Prashant Gupta, Divya Mehrotra, Himanshu Dandu, Neera Kohli, Veerendra Verma, Apjit Kaur, Neeraj Kumar, Vikas Prabhu, Manish Kumar Singh, Riddhi Jaiswal, Brijesh Mishra, Bal Krishna Ojha, Nitin Dutt Bhardwaj, Virendra Atam, Bipin Puri
Format:	Article
Language:	English
Published:	Elsevier 2021-10-01
Subjects:	COVID-19 Mucormycosis Rhino-orbital-cerebral mucormycosis Anti-fungal Amphotericin Staging
Online Access:	http://www.sciencedirect.com/science/article/pii/S2212426821000841